Gary, predicting stocks is hard, predicting biotech stocks is harder still. The rules and regulations they require are slow and laborious and seemingly more succeptable to attacks by competing companies, shorts, and idiots like AF. As I said, nobody has been right on the timing, and nwbo does not have a reputation of fast accomplishments. I'm not sure if what is to be discussed next week requires the UK approval to come first, that just sounds like quessing, again. If the week goes by with no news, we will slip into August and more guesses, then September, etc. Worse than watching water boil, but unlike cvm, we already know the data is good. Meanwhile several stocks I was in have gone up considerably, like apple, tsla and Amazon, which creates even more frustration. It is what it is. I will be so glad when the waiting is over and more news follows approval, whenever the hell that will be. Sigh...
Market Data 
Markets 
AI
